The concept of pre-COPD: development and feasibility in primary health care
- Authors: Andreeva E.A.1, Pokhaznikova M.A.2, Turusheva A.V.2, Popov V.V.1, Kuznetsova O.Y.2
-
Affiliations:
- Northern State Medical University
- North-Western State Medical University named after I.I. Mechnikov
- Issue: Vol 27, No 1 (2023)
- Pages: 21-30
- Section: Original study article
- URL: https://journal-vniispk.ru/RFD/article/view/132680
- DOI: https://doi.org/10.17816/RFD283633
- ID: 132680
Cite item
Abstract
BACKGROUND: Chronic obstructive pulmonary disease is often not diagnosed as a preventable disease. The primary physician needs a diagnostic tool to detect chronic obstructive pulmonary disease at an early stage.
AIM: To develop the concept of early detection of chronic obstructive pulmonary disease through a diagnostic tool that stratifies patients according to the risk of disease development.
MATERIALS AND METHODS: Random sample of persons 35–70 years from the lists provided by 15 polyclinics of Saint Petersburg and Arkhangelsk (cross-sectional study, n = 2388). Cohort prospective study (respondents with fixed or variable obstruction, n = 167). All respondents were asked about demographic data, smoking history, risk factors, and the presence of symptoms. Spirometry with a bronchodilator was performed for all participants.
RESULTS: Fixed obstruction was found in 6.8% of the participants in the first phase; obstruction was associated with male sex, smoking status over 10 packs/years, age over 55 years, chronic cough and shortness of breath. Of the 65 members of the cohort with variable obstruction, 23.1% had a fixed obstruction after a year, the risk factors of which were a smoking status of more than 10 packs/years, a night cough and forced expiratory volume in 1 second less than lower limit of normal.
CONCLUSIONS: Based on the results of the two phases of the study, a diagnostic tool was developed for the early detection of chronic obstructive pulmonary disease in the general population by identifying a group of people with preserved lung function and high-risk chronic obstructive pulmonary disease factors.
Full Text
##article.viewOnOriginalSite##About the authors
Elena A. Andreeva
Northern State Medical University
Author for correspondence.
Email: klmn.69@mail.ru
ORCID iD: 0000-0002-3917-154X
SPIN-code: 3543-4005
Scopus Author ID: 56537990200
ResearcherId: J-7662-2017
MD, Cand. Sci. (Med.), Assistant Professor
Russian Federation, ArkhangelskMarina A. Pokhaznikova
North-Western State Medical University named after I.I. Mechnikov
Email: pokmar@mail.ru
ORCID iD: 0000-0001-9894-5974
SPIN-code: 3387-0226
Scopus Author ID: 56801758400
ResearcherId: 0-4115-2014
MD, Cand. Sci. (Med.), Assistant Professor
Russian Federation, Saint PetersburgAnna V. Turusheva
North-Western State Medical University named after I.I. Mechnikov
Email: anna.turusheva@szgmu.ru
ORCID iD: 0000-0003-3347-0984
SPIN-code: 9658-8074
Scopus Author ID: 57189466350
ResearcherId: U-3654-2017
MD, Cand. Sci. (Med.), Assistant Professor
Russian Federation, Saint PetersburgVladimir V. Popov
Northern State Medical University
Email: fmi2008@mail.ru
ORCID iD: 0000-0003-2281-0576
SPIN-code: 9788-3049
Scopus Author ID: 55913672600
ResearcherId: F-7438-2018
MD, Dr. Sci. (Med.), Professor
Russian Federation, ArkhangelskOlga Y. Kuznetsova
North-Western State Medical University named after I.I. Mechnikov
Email: oukuznetsova@mail.ru
ORCID iD: 0000-0002-2440-6959
SPIN-code: 7200-8861
Scopus Author ID: 24448739500
ResearcherId: O-4056-2014
MD, Dr. Sci. (Med.), Professor
Russian Federation, Saint PetersburgReferences
- The Global Strategy for the Diagnosis, Management and Prevention of Chronic obstructive pulmonary disease. Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2023 [Internet]. Available from: https://goldcopd.org/2023-gold-report-2/. Accessed: 23.02.2023.
- Adeloye D, Song P, Zhu Y, et al. NIHR RESPIRE Global Respiratory Health Unit. Global, regional, and national prevalence of, and risk factors for, chronic obstructive pulmonary disease (COPD) in 2019: a systematic review and modelling analysis. Lancet Respir Med. 2022;10(5):447–458. doi: 10.1016/S2213-2600(21)00511-7
- Klinicheskie rekomendatsii. Khronicheskaya obstruktivnaya bolezn’ legkikh. [Internet]. Available from: https://cr.minzdrav.gov.ru/recomend/603. Accessed: 23.02.2023. (In Russ.).
- US Preventive Services Task Force; Mangione CM, Barry MJ, Nicholson WK, et al. Screening for Chronic Obstructive Pulmonary Disease: US Preventive Services Task Force Reaffirmation Recommendation Statement. JAMA. 2022;327(18):1806–1811. doi: 10.1001/jama.2022.5692
- Agustí A, Celli B. Natural history of COPD: gaps and opportunities. ERJ Open Res. 2017;3(4):00117–2017. doi: 10.1183/23120541.00117-2017
- Lowe KE, Regan EA, Anzueto A, et al. COPDGene® 2019: Redefining the diagnosis of chronic obstructive pulmonary disease. Chronic Obstr Pulm Dis. 2019;6(5):384–399. doi: 10.15326/jcopdf.6.5.2019.0149
- Han MK, Agusti A, Celli BR, et al. From GOLD 0 to Pre-COPD. Am J Respir Crit Care Med. 2021;203(4):414–423. doi: 10.1164/rccm.202008-3328PP
- Stolz D, Mkorombindo T, Schumann DM, et al. Towards the elimination of chronic obstructive pulmonary disease: a Lancet Commission. Lancet. 2022;400(10356):921–972. doi: 10.1016/S0140-6736(22)01273-9
- Klinicheskie rekomendatsii. Khronicheskii bronkhit (25.08.2021) [Internet]. Available from: https://cr.minzdrav.gov.ru/recomend/655. Accessed: 23.02.2023. (In Russ.)
- Andreeva E, Pokhaznikova M, Lebedev A, et al. The RESPECT study: Research on the Prevalence and the diagnosis of COPD and its Tobacco-related etiology: a study protocol. BMC Public Health. 2015;15:831. doi: 10.1186/s12889-015-2161-z
- Buhr RG, Barjaktarevic IZ, Quibrera PM, et al. SPIROMICS Investigators. Reversible Airflow Obstruction Predicts Future Chronic Obstructive Pulmonary Disease Development in the SPIROMICS Cohort: An Observational Cohort Study. Am J Respir Crit Care Med. 2022;206(5):554–562. doi: 10.1164/rccm.202201-0094OC
- Global Lung Function Initiative [Internet]. Available from: https://www.ersnet.org/science-and-research/ongoing-clinical-research-collaborations/ the-global-lung-function-initiative/ Accessed: 24.02.2023.
- Pokhaznikova MA, Andreeva EA, Kuznetsova OYu. An experience of performing spirometry by trained general practitioners. Medical alphabet. 2020;(25):34–36. (In Russ.). doi: 10.33667/2078–5631–2020–25–34–36
- Wan ES, Balte P, Schwartz JE, et al. Association between preserved ratio impaired spirometry and clinical outcomes in US adults. JAMA. 2021;326(22):2287–2298. doi: 10.1001/jama.2021.20939
- Yawn BP, Martinez FJ. POINT: Can Screening for COPD Improve Outcomes? Yes. Chest. 2020;157(1):7–9. doi: 10.1016/j.chest.2019.05.034
Supplementary files
